FMC (FMC)
(Delayed Data from NYSE)
$62.69 USD
+0.17 (0.27%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $62.70 +0.01 (0.02%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$62.69 USD
+0.17 (0.27%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $62.70 +0.01 (0.02%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth C Momentum C VGM
Zacks News
Chemical Stock Q2 Earnings Due on Aug 3: DD, FMC, WLK & KWR
by Anindya Barman
Strong end-market demand and the benefits of strategic measures are likely to have aided the performance of chemical companies in Q2. Let's see how DD, FMC, WLK and KWR are poised ahead of their earnings releases.
FMC Corp (FMC) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
FMC Corp (FMC) is likely to have benefited from higher demand and contributions of new products amid cost headwinds in Q2.
FMC (FMC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HUN vs. FMC: Which Stock Is the Better Value Option?
by Zacks Equity Research
HUN vs. FMC: Which Stock Is the Better Value Option?
HUN or FMC: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HUN vs. FMC: Which Stock Is the Better Value Option?
Here's Why You Should Hold Onto FMC Corp (FMC) Stock for Now
by Zacks Equity Research
FMC Corp (FMC) is in an advantageous position owing to healthy demand, investments and new product offerings, while facing a few concerns related to cost and volume challenges.
DOW vs. FMC: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DOW vs. FMC: Which Stock Is the Better Value Option?
FMC Corp (FMC) Obtains U.S. EPA Approval for Fluindapyr
by Zacks Equity Research
FMC Corp (FMC) receives EPA registration for its novel fungicide, thereby providing growers and golf course superintendents an effective technique to treat crop and turf diseases.
FMC (FMC) Up 0.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
FMC (FMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
BASFY vs. FMC: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
BASFY vs. FMC: Which Stock Is the Better Value Option?
DOW vs. FMC: Which Stock Is the Better Value Option?
by Zacks Equity Research
DOW vs. FMC: Which Stock Is the Better Value Option?
FMC Corp (FMC) Earnings and Revenues Surpass Estimates in Q1
by Zacks Equity Research
Lower sales across EMEA, North America and Latin America hurt FMC Corp's (FMC) top line in Q1.
FMC (FMC) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
FMC (FMC) delivered earnings and revenue surprises of 0.66% and 2.17%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
4 Diversified Chemical Stocks Set to Ride the Industry's Upswing
by Anindya Barman
An upturn in demand in major end-markets from the pandemic-induced slump should enable the Zacks Chemicals Diversified industry to thrive. DOW, PPG, OLN and CBT are set to gain from the improving industry fundamentals and strategic actions.
FMC Corp (FMC) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
FMC Corp (FMC) is likely to have faced headwind from lower volumes in the first quarter.
Analysts Estimate FMC (FMC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FMC Corp (FMC) Collaborates With UPL for Rynaxypyr Active
by Zacks Equity Research
FMC Corp's (FMC) collaboration with UPL Ltd will increase its manufacturing footprint and expand capacity for Rynaxypyr active.
FMC Corp (FMC) Beats Earnings and Revenue Estimates in Q4
by Zacks Equity Research
FMC Corp (FMC) benefits from strong volume gains in EMEA and Asia in the fourth quarter.
FMC (FMC) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
FMC (FMC) delivered earnings and revenue surprises of 2.90% and 1.47%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Chemical Stock Earnings to Watch on Feb 9: DD, FMC & More
by Anindya Barman
A rebound in demand in major markets and benefits of self-help actions are likely to have aided the performance of chemical companies in Q4. Let's see how DD, FMC, GRA and AVNT are poised ahead of their earnings releases.
FMC Corp (FMC) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
FMC Corp's (FMC) fourth-quarter 2020 results are likely to reflect the impact of supply chain disruptions stemming from pandemic-related factors and challenges in Latin America.
Earnings Preview: FMC (FMC) Q4 Earnings Expected to Decline
by Zacks Equity Research
FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
U.S. Steel (X) to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
U.S. Steel's (X) Q4 results are likely to have benefited from improved demand across end markets and higher steel prices.
FMC Corp (FMC) Cuts Q4 View on North and Latin America Softness
by Zacks Equity Research
FMC Corp (FMC) reduces outlook for the fourth quarter of 2020 due to impact on sales in its North America and Latin America businesses.
What's in Store for Eastman Chemical (EMN) in Q4 Earnings?
by Zacks Equity Research
Benefits of cost-management actions are expected to get reflected on Eastman Chemical's (EMN) fourth-quarter results.